Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
OPTIMIZED GLOBAL POSITIONING SYSTEM CORRECTION MESSAGE FOR INTEROPERABLE TRAIN COMMAND MESSAGING TRANSPORT
UndeterminedMA50750A
Owner:BNSF RAILWAY COMPANY
Coated steel substrate, process for manufacturing a coated steel substrate, process for manufacturing a steel product, and steel product
UndeterminedMA55360A
Owner:ARCELORMITTAL SA +1
VARIANT III EPIDERMAL GROWTH FACTOR-MESOTHELIN RECEPTOR FUSIONS AND THEIR METHODS OF USE
UndeterminedMA44379A
Owner:ADURO BIOTECH INC
A composition essentially free of water and comprising at least one fungal spore-forming biopesticide, a polyether-modified trisiloxane, and fumed or precipitated silica.
ActiveMA40779A
Owner:BAYER CROPSCIENCE BIOLOGICS GMBH
DRUG TARGET FOR IDIOPATHIC PULMONARY FIBROSIS
UndeterminedMA56090A
Owner:NAT INST OF BIOLOGICAL SCI BEIJING
ANTI-TNF ANTIBODY COMPOSITIONS INTENDED FOR USE IN METHODS OF TREATMENT OF PSORIATIC ARTHRITIS
UndeterminedMA54814A
Owner:JANSSEN BIOTECH INC
COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND HERBICIDES THAT INHIBIT FATTY ACID AND LIPID SYNTHESIS
UndeterminedMA54154A
Owner:CORTEVA AGRISCIENCE LLC
SYSTEMS AND METHODS FOR PERFORMING REAL-TIME GLYCAN ASSAY ON A SAMPLE
UndeterminedMA49758A
Owner:AMGEN INC
SYSTEM AND METHOD FOR THE SIMULTANEOUS MANAGEMENT OF MULTIPLE DESIGNATION DEVICES
UndeterminedMA50393A
Owner:IMMERSION CORP
ORGANIC PHASE CHANGE MATERIAL GEOPOLYMER, PREPARATION PROCESSES AND USES
UndeterminedMA46468A
Owner:COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
PROTECTIVE SCREEN AGAINST ARTHROPODS AND ITS MANUFACTURING PROCESS
UndeterminedMA52358A
Owner:CAPITAINE FRANCOIS +2
OXAZINE DERIVATIVE FOR USE IN THE PREVENTION OF ALZHEIMER'S DISEASE IN AT-RISK PATIENTS
UndeterminedMA45719A
Owner:NOVARTIS AG
METHOD FOR PREPARING A DRY POWDER FORMULATION CONTAINING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC AGENT
Owner:CHIESI FARMACEUTICI SPA
Compositions for producing glass coatings by means of an inkjet printing process and their use
UndeterminedMA50234A
Owner:MANKIEWICZ GEBR & CO GMBH & CO KG
A plastic part of a motor vehicle equipped with electrically conductive elements distributed over its surface.
UndeterminedMA49112A
Owner:COMPAGNIE PLASTIC OMNIUM SA
NY-ESO-1 T-LYMPHOCYTE RECEPTORS AND THEIR METHODS OF USE
UndeterminedMA53981A
Owner:REGENERON PHARMACEUTICALS INC
BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND THEIR USES
UndeterminedMA42546A
Owner:PHARMACYCLICS LLC
TRANSPARENT TEXTILE WITH SELF-ADHESIVE PROPERTIES FOR HUMID ENVIRONMENTS
UndeterminedMA42968A
Owner:LAMPE TEXTILES
COMPOUNDS AND COMPOSITIONS, AND ASSOCIATED USES
UndeterminedMA45857A
Owner:SUMITOMO PHARMA AMERICA INC
COLD-ROLL-ON AND COATED STEEL SHEET AND ITS MANUFACTURING PROCESS
UndeterminedMA56012A
Owner:ARCELORMITTAL SA
CENTRAL BEAM FOR REAR VEHICLE CHASSIS INCLUDING A REINFORCING PROFILE AT THE REAR
UndeterminedMA49027A
Owner:PSA AUTOMOBILES SA
CONTROL FOR MOTOR VEHICLES EQUIPPED WITH A SEALING SYSTEM INCLUDING A PROTECTED VENT
UndeterminedMA49252A
Owner:PSA AUTOMOBILES SA
Edible coating composition for coating fresh harvested produce
Owner:LIQUIDSEAL HLDG BV
CANCER TREATMENT METHODS BY INHIBITION OF THE UBIQUITIN E2 K CONJUGATION ENZYME (UBE2K)
UndeterminedMA53623A
Owner:BERG LLC
CD98 LINKAGE CONSTRUCTIONS FOR THE TREATMENT OF BRAIN TUMORS
UndeterminedMA71685A
Owner:JANSSEN BIOTECH INC
SOLID OXIDE ELECTROLYSIS (SOE) PLANT AND METHOD FOR PERFORMING SOLID OXIDE ELECTROLYSIS
ActiveMA71443A
Owner:HALDOR TOPSOE AS
MOLDING METHOD FOR A WIND TURBINE BLADE SHELL COMPONENT
UndeterminedMA45297A
Owner:LM WP PATENT HLDG AS
N-SUBSTITUTED INDOLE DERIVATIVES
InactiveMA49127Areduced dosage requirementgood metabolic stability
Owner:IDORSIA PHARMACEUTICALS LTD
PHARMACEUTICAL COMBINATIONS OF ZONISAMIDE AND PRAXIPEXOLE, AND ASSOCIATED METHODS, FOR THE TREATMENT OF SYNUCLEINOPATHIES
UndeterminedMA48791A
Owner:CHASE THERAPEUTICS CORP
TRIPLE COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS, ACETYLCHOLINESTERASE INHIBITORS, AND NMDA RECEPTOR ANTAGONISTS
ActiveMA45002A
Owner:SUVEN LIFE SCI LTD
PEST CONTROL COMPOSITION AND PEST CONTROL METHOD
Owner:ISHIHARA SANGYO KAISHA LTD
UREA FUMARATE SALT (R)-3-(1-(2,3-DICHLORO-4-(PYRAZIN-2-YL)PHENYL)-2,2,2-TRIFLUOROETHYL)-1-METHYL-1-(1-METHYLPIPERIDIN-4-YL), PROCESSES OF PREPARATION AND USES THEREOF
UndeterminedMA51132A
Owner:HELSINN HEALTHCARE SA
METHODS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTORS
UndeterminedMA46968A
Owner:BIOVERATIV THERAPEUTICS INC +1
TREATMENT METHODS FOR CROHN'S DISEASE WITH A SPECIFIC ANTI-IL23 ANTIBODY
ActiveMA54132A
Owner:JANSSEN BIOTECH INC
METHOD FOR PREPARING FORMULATIONS FOR INHALATION
UndeterminedMA40446A
Owner:ARVEN ILAC SANAYI VE TICARET
Washing machine drum comprising at least one parallelepiped-shaped compartment and washing machine comprising it
ActiveMA53384A
Owner:BARREAU DENIS +1
AFABICIN FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS INVOLVING A BIOFILM
UndeterminedMA56184A
Owner:DEBIOPHARM INTERNATIONAL SA
COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN-RELATED DISEASES
UndeterminedMA51203A
Owner:IDORSIA PHARMACEUTICALS LTD
METHOD AND INSTALLATION FOR SUPPLYING ENERGY, PARTICULARLY LOW-CARBON THERMAL ENERGY, IN AT LEAST ONE BUILDING OR SIMILAR STRUCTURE, AND RELATED SYSTEM
UndeterminedMA71373A
Owner:ACCENTA
INDOLE DERIVATIVES USEFUL AS DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
UndeterminedMA46859A
Owner:MERCK SHARP & DOHME CORP
WATER RESISTANCE ADDITIVE FOR NITRATE-FUEL EXPLOSIVES (ANFO)
UndeterminedMA44754A
Owner:CLARIANT INT LTD
RAIL MOUNTING DEVICE AND METHOD FOR FIXING RAILS TO A REINFORCED CONCRETE RAILWAY SLEEPER
UndeterminedMA48607A
Owner:HR SYST HUNGARY ZRT
DEVICE FOR RAISE AND LOWERING A SPARE WHEEL ON A VEHICLE WITH CONTACT SURFACES
UndeterminedMA56198A
Owner:PROMA
METHODS OF USING CD24 FOR THE PREVENTION AND TREATMENT OF LEUKEMIA RELAPSE
UndeterminedMA52811A
Owner:ONCOIMMUNE INC +1
METHOD FOR IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND TO SUCH EPITOPES, AND ASSOCIATED USES
UndeterminedMA45455A
Owner:JUNO THERAPEUTICS INC
1,2-DIHYDRO-3H-PYRROLO[1,2-C]IMIDAZOL-3-ONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
InactiveMA39707A
Owner:IDORSIA PHARMACEUTICALS LTD
COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS
UndeterminedMA43943A
Owner:IGNYTA INC
DEVICE FOR GENERATING A MAGNETIC FIELD AND METHOD FOR GENERATING A MAGNETIC FIELD
UndeterminedMA42800A
Owner:CARDLAB APS
METHODS FOR MANUFACTURED SECURITY DOCUMENTS AND SECURITY DEVICES
InactiveMA42909A
Owner:DE LA RUE INTERNATIONAL LTD
STRUCTURAL PARTS INCLUDING AN OVERMOLDED INSERT
UndeterminedMA47160A
Owner:COMPAGNIE PLASTIC OMNIUM SA
AUTOMATIC CONSTANT PRESSURE DEVICE FOR HUB-ON TIRE SYSTEM
InactiveMA45314Aconstant air pressureavoid tire burst
Owner:CITIC DICASTAL CO LTD
ANTI-T LYMPHOCYTE ANTIGEN-BINDING MOLECULE FOR USE IN COMBINATION WITH A CYTOKINE INHIBITOR
UndeterminedMA56131A
Owner:CHUGAI PHARMA CO LTD
CX3CR1 BONDING COMPOUNDS, THEIR USES AND ASSOCIATED PROCESSES
UndeterminedMA71543A
Owner:SANOFI SA(FR) +1
APPLICATION OF A COMBINATION OF NICOSULFURON AND CLOMAZONE ON CROPS BELONGING TO THE FABACEAE / LEGUMINOSAE FAMILY
UndeterminedMA50227A
Owner:SUMI AGRO HUNGARY KFT
TREATMENT METHODS FOR MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIA
UndeterminedMA41119A
Owner:ACCELERON PHARMA INC
CXCR5 inhibitor binder-active ingredient conjugates comprising binding elements that can be enzymatically broken down and exhibiting an improved action profile
UndeterminedMA71421A
Owner:BAYER AG
EXTRA LOW VOLTAGE OUTDOOR LIGHTING SYSTEM, LUMINAIRE, POWER SUPPLY AND ASSEMBLY AND METHOD FOR PROVIDING OUTDOOR LIGHTING
UndeterminedMA45056A
Owner:IN LITE DESIGN BV
METHODS FOR TREATMENT USING SPECIFIC CHIMERICAL ANTIGENIC RECEPTORS OF B LYMPHOCYTE MATURATION ANTIGEN
UndeterminedMA54078A
Owner:JUNO THERAPEUTICS INC +1
ARIPIPRAZOLE FORMULATIONS WITH HIGHER INJECTION RATES
UndeterminedMA39495A
Owner:ALKERMES PHARMA IRELAND LTD
PROSTATE CANCER TREATMENT METHODS WITH AN ANTI-PSMA / CD3 ANTIBODY
UndeterminedMA55717A
Owner:JANSSEN BIOTECH INC
OPTIMIZED ASSEMBLY HEAT TRANSFER FLUID HEAT EXCHANGER AND A PHASE CHANGE MATERIAL THERMAL ENERGY STORAGE DEVICE INCLUDING SAID EXCHANGER
ActiveMA43656A
Owner:COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS
UndeterminedMA52004A
Owner:BIOGEN MA INC
NUCLEIC ACIDS TO INHIBIT THE EXPRESSION OF A TARGET GENE COMPRISING PHOSPHORODITHIOATE BONDS
UndeterminedMA51707A
Owner:SILENCE THERAPEUTICS GMBH
SPECIFIC TRICHOME PROMOTERS FOR THE HANDLING OF CANNABINOIDS AND OTHER COMPOUNDS IN GLANDULAR TRICHOMES
UndeterminedMA45611A
Owner:22ND CENTURY LTD LLC
A capsule for insertion into the head of a hookah, a machine in the tobacco processing industry, and a method for manufacturing such a capsule.
UndeterminedMA46686A
Owner:KORBER TECHNOLOGIES GMBH
SYSTEM AND METHOD FOR DETERMINING THE STRENGTH OF A STRUCTURE
UndeterminedMA71711A
Owner:LM WIND POWER AS
ROTOR SYSTEM, TRANSMISSION AND SENSOR ELEMENTS OPTIMIZING THE VERTICAL AXIS WIND TURBINE
UndeterminedMA49787A
Owner:TORRECILLA CONTRERAS JOSE ANTONIO
VEHICLE DOOR ANTI-COLLISION WARNING SYSTEM, VEHICLE GLASS STRUCTURE AND VEHICLE DOOR ANTI-COLLISION WARNING METHOD
UndeterminedMA55764A
Owner:SAINT GOBAIN VITRAGE SA
NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS
UndeterminedMA71381A
Owner:LES LAB SERVIER SA +1
ULTRASONIC SURGICAL INSTRUMENT WITH OPPOSITE THREAD DRIVE FOR END EFFECTOR JOINT
UndeterminedMA54029A
Owner:ETHICON INC
INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTIC SPHEROIDS
UndeterminedMA52540A
Owner:CASE WESTERN RESERVE UNIV
MONO- OR DI-SUBSTITUTED INDOLES USED AS DENGUE VIRUS REPLICATION INHIBITORS
Owner:JANSSEN PHARMACEUTICALS INC +1
Antibodies directed against the chemokine receptor 1 and their therapeutic uses
UndeterminedMA52174A
Owner:OSE IMMUNOTHERAPEUTICS SA
OLIGONUCLEOTIDES TO MODULATE THE EXPRESSION OF TMEM106B
UndeterminedMA51795A
Owner:F HOFFMANN LA ROCHE & CO AG
T-lymphocyte receptors, limited to class I HLA antigen, having antigenic specificity for any mutated RAS protein
UndeterminedMA51042A
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
CXCL8 INHIBITOR AND ASSOCIATED PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CANCER-RELATED FATIGUE
UndeterminedMA51471A
Owner:DOMPE FARMACEUTICI SPA
COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INFLAMMATION
UndeterminedMA52961A
Owner:AXCELLA HEALTH INC
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODIES
UndeterminedMA56523A
Owner:JANSSEN SCI IRELAND UC
TUBULAR STRUCTURAL PROFILE AND CONSTRUCTION SYSTEM, OBTAINED BY CUTTING AND BENDING A SEMI-RIGID AND FOLDABLE LAYER, WITH FOUR VARIOUSLY ORTHOGONAL SHEETS ASSEMBLED IN FOLD LINES AND INTERNAL DIAGONAL LINES ASSEMBLING TWO OPPOSING FOLD LINES, AND AT LEAST ONE TAB, WHICH COINCIDES WITH AT LEAST ONE GROOVE
UndeterminedMA54268A
Owner:CARLOS TOMAS VERAZA OSORIO PUBLICIDAD SPA
BARRIER LAYER AND ITS USE IN PLASTIC SUBSTATE COATING SYSTEMS
ActiveMA40778A
Owner:MANKIEWICZ GEBR & CO GMBH & CO KG
METHOD FOR TREATING ORGAN DISEASES OR DISORDERS WITH ASK1 INHIBITORS
UndeterminedMA71567A
Owner:SEAL ROCK THERAPEUTICS INC
IMIDAZOPYRAZINONES USED AS PDE1 INHIBITORS
InactiveMA41977AAvoid unnecessary influence
Owner:H LUNDBECK AS
ADMINISTRATION OF A BISPECIFIC CONSTRUCTION BINDING TO CD33 AND CD3 INTENDED FOR USE IN A TREATMENT PROCESS FOR MYELOID LEUKEMIA
UndeterminedMA44726A
Owner:AMGEN RESEARCH (MUNICH) GMBH
Immunogenic composition with adjuvant against Neisseria meningitidis B
UndeterminedMA71695A
Owner:SANOFI PASTEUR INC
Apparatus for electrical measurement and control
UndeterminedMA39014A
Owner:SOCI T ANONYME DES ETS CATU
REGIMEN ADHERENCE MEASURE FOR INSULIN THERAPY BASED ON GLUCOSE MEASURES AND INSULIN PEN DATA
UndeterminedMA45538A
Owner:NOVO NORDISK AS
Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
UndeterminedMA40573A
Owner:MACROGENICS INC
Menin-MLL Bridged Bicyclic Inhibitors and Methods of Use
UndeterminedMA43823A
Owner:KURA ONCOLOGY INC +1
Pharmaceutical combination intended for use in age-related and / or degenerative diseases
UndeterminedMA53007A
Owner:REJUVENATE BIOMED